Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 févr. 2026 08h00 HE | Source: EQV Ventures Acquisition Corp.

Presidio Announces Proposed $1 Billion Acquisition Financing Facility with Goldman Sachs

Acquisition Facility expected to accelerate asset acquisition strategy Fort Worth, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Presidio Investment Holdings LLC (“Presidio” or the “Company”), a...
05 févr. 2026 07h15 HE | Source: Jiuzi Holdings Inc.

Multiple Crypto Strategic Investment Institutions Commit US$40 Million in Assets to Jiuzi Holdings at a Price Not Lower Than US$1.50 per Share, with the Transaction to Be Completed Within Two Weeks

HANGZHOU, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Jiuzi Holdings, Inc. (Nasdaq: JZXN) (the “Company”) today announced that it has entered into strategic arrangements with several Crypto-focused...
05 févr. 2026 07h00 HE | Source: Can-Fite BioPharma Ltd.

Can-Fite: Patient with Decompensated Liver Cirrhosis Successfully Undergoes Liver Transplantation Following Treatment with Namodenoson

Namodenoson Provided Clinical Stabilization as a Potential Bridge to Transplant in Advanced Liver Failure Ramat Gan, Israel, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE...
04 févr. 2026 08h30 HE | Source: Golden Sun Technology Group Limited

Golden Sun Technology Group Limited Announces Corporate Name Change

Shanghai, China, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Golden Sun Technology Group Limited (the “Company” or “Golden Sun”), announced today that it has changed its corporate name from “Golden Sun...
27 janv. 2026 08h40 HE | Source: Maris-Tech Ltd.

Maris-Tech Receives Follow-On Purchase Order for Intelligence Gathering Application

The success of the development phase moves the technology to operational product deployment Rehovot, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech”...
16 déc. 2025 08h45 HE | Source: Clearmind Medicine Inc.

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100

Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and...
12 déc. 2025 08h32 HE | Source: Clearmind Medicine Inc.

Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment

Vancouver, Canada, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery...
12 déc. 2025 06h32 HE | Source: Clearmind Medicine Inc.

Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Vancouver, Canada, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery...
11 déc. 2025 07h00 HE | Source: Purple Biotech Ltd.

Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025

Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct tri-specific antibodies, IM1240 and IM1305, targeting different tumor antigens ...
09 déc. 2025 07h00 HE | Source: Triller Group Inc.

ILLR Secures Nasdaq Listing Extension with Clear Path to Full Compliance

Los Angeles, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Triller Group Inc. (Nasdaq: ILLR) (“Triller Group”, or “the Company”) announced today that the Nasdaq Hearings Panel has granted an extension period...

Page suivante